Cost-Effectiveness Analysis of Xiyanping Injection (Andrographolide Sulfonate) for Treatment of Adult Community Acquired Pneumonia: A Retrospective, Propensity Score-Matched Cohort Study

Table 5

Characteristics at baseline after PSM: Xiyanping combination versus cephalosporin.

Variable	Xiyanping combination		Cephalosporin		P
	N	%	N	%
Sample size	180		180
Age (y), mean ± SD	57.33±19.06		58.95±19.09		0.578
Gender
Male	91	50.6%	87	48.3%	0.673
Female	89	49.4%	93	51.7%	0.673
Marriage
Widowed	144	80.0%	140	77.8%	0.605
Married	32	17.8%	31	17.2%	0.890
Single	3	1.7%	8	4.4%	0.126
Divorced or others	1	0.6%	1	0.6%	1
Occupation
Peasants	8	5.1%	8	5.2%	0.968
Employment	41	26.1%	34	22.1%	0.405
Unemployment	70	44.6%	72	46.8%	0.701
Retirement	0	0.0%	0	0.0%	1
Unknown	32	20.4%	36	23.4%	0.523
Others	6	3.8%	4	2.6%	0.541
Comorbidities
Yes	5	2.8%	1	0.6%	0.100
No	175	97.2%	179	99.4%	0.100
CRP difference	59.56±50.62		72.46±70.55		0.290
Neutrophil proportion difference	79.71±13.75		79.31±10.98		0.860
Neutrophil count difference	8.07±4.81		7.32±4.16		0.380
White blood cell count difference	9.81±5.01		8.98±4.38		0.350